Skip to content
★ Sign in to follow
DA

David A. Metcalfe

Chief Technology Officer
Nextgen Healthcare, Inc.
Total declarations
42
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€3.2M

Latest filing published 28 Dec 2022 for Nextgen Healthcare, INC., €373k.

Filing timeline

BuySale
David A. Metcalfe

Insider track record

Disclosed buys
0
Disclosed sells
5
Signal history

David A. Metcalfe: trading record in brief

David A. Metcalfe (senior executive) discloses dealings in Nextgen Healthcare, Inc. to SEC (Form 4). We count 42 filings; the first trade dates from 29 December 2016 and the latest from 27 December 2022.

No open-market purchase appears, only 5 sales worth €3.2M. Besides market trades, the filings include 28 share grants and 9 option exercises. In 2022 alone, the filings show no purchases and 5 sales.

The latest filing, published on 28 December 2022, reports a share grant of €373k in Nextgen Healthcare, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to David A. Metcalfe

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations42 total

25 of 42 declarations